Anthracene

Anthracene

SCHEMBL175144

c1ccc2[nH]cnc2c1.c1ccc2cc3ccccc3cc2c1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
MMP12 P39900 1/20 0.47
PRKCI P41743 1/20 0.47
MAPT P10636 3/20 0.46
RAD52 P43351 1/20 0.46
QPCT Q16769 2/20 0.45
QPCTL Q9NXS2 2/20 0.45
HTT P42858 1/20 0.45
GLA P06280 2/20 0.44
ACHE P22303 1/20 0.44
NQO2 P16083 1/20 0.43
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PDPK1 O15530 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acridine SCHEMBL9437430 0.92 ALDH1A1 (0.58) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
Naphthalene SCHEMBL29363450 0.91 KDM4E (0.46) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
Naphthalene SCHEMBL9738608 0.91 KDM4E (0.46) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
Naphthalene SCHEMBL15819597 0.91 KDM4E (0.46) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
Benzimidazole SCHEMBL29358377 0.89
Benzimidazole SCHEMBL29408372 0.89
Benzimidazole SCHEMBL461969 0.89 SMN1; SMN2 (0.50) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
Benzimidazole SCHEMBL10931770 0.89 SMN1; SMN2 (0.50) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
Benzimidazole SCHEMBL6009 0.89
Phenazine SCHEMBL28566498 0.87 KDM4E (0.50) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11957047-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-04-09 US disclosed
CN-117730638-A Printing method by combining inks 默克专利有限公司 2024-03-19 CN disclosed
WO-2023237458-A1 METHOD OF PRINTING A FUNCTIONAL LAYER OF AN ELECTRONIC DEVICE BY COMBINING INKS MERCK PATENT GMBH (DE) 2023-12-14 WO disclosed
CN-115010701-B Preparation method of nitrogen-containing heterocyclic derivative 浙江百可半导体材料有限公司 2023-10-13 CN disclosed
CN-114933586-B Nitrogen-containing heterocyclic derivative and application thereof 浙江百可半导体材料有限公司 2023-10-10 CN disclosed
EP-3360175-B1 FORMULATIONS COMPRISING AT LEAST TWO ORGANIC SEMICONDUCTING COMPOUNDS AND AT LEAST TWO SOLVENTS MERCK PATENT GMBH (DE) 2023-05-17 EP disclosed
US-20230130110-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-27 US disclosed
EP-4139971-A1 EMULSIONS COMPRISING ORGANIC FUNCTIONAL MATERIALS Merck Patent GmbH (DE) 2023-03-01 EP disclosed
WO-2023012084-A1 A PRINTING METHOD BY COMBINING INKS MERCK PATENT GMBH (DE) 2023-02-09 WO disclosed
CN-115700058-A Emulsions comprising organic functional materials 默克专利有限公司 2023-02-03 CN disclosed
WO-2012013270-A1 NANOCRYSTALS IN DEVICES MERCK PATENT GMBH (DE) 2012-02-02 WO disclosed
WO-2012013272-A1 QUANTUM DOTS AND HOSTS MERCK PATENT GMBH (DE) 2012-02-02 WO disclosed
WO-2011147522-A1 COMPOSITIONS COMPRISING QUANTUM DOTS MERCK PATENT GMBH (DE) 2011-12-01 WO disclosed
WO-2011110275-A2 RADIATIVE FIBERS MERCK PATENT GMBH (DE) 2011-09-15 WO disclosed
WO-2011110277-A1 FIBERS IN THERAPY AND COSMETICS MERCK PATENT GMBH (DE) 2011-09-15 WO disclosed
WO-2011076323-A1 FORMULATIONS COMPRISING PHASE-SEPARATED FUNCTIONAL MATERIALS MERCK PATENT GMBH (DE) 2011-06-30 WO disclosed
WO-2011076314-A1 ELECTROLUMINESCENT FORMULATIONS MERCK PATENT GMBH (DE) 2011-06-30 WO disclosed
WO-2011076326-A1 ELECTROLUMINESCENT FUNCTIONAL SURFACTANTS MERCK PATENT GMBH (DE) 2011-06-30 WO disclosed
WO-2011069590-A1 THERAPEUTIC AND COSMETIC ELECTROLUMINESCENT COMPOSITIONS MERCK PATENT GMBH (DE) 2011-06-16 WO disclosed
WO-2011015265-A2 ELECTRONIC DEVICES COMPRISING MULTI CYCLIC HYDROCARBONS MERCK PATENT GMBH (DE) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11957047-B2 Organic electroluminescent materials and devices SOD1, PIEZO1, L1CAM KDM4E 4026/4885ALDH1A1 606/4885HPGD 3064/4885
US-20230130110-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES SOD1, PIEZO1, L1CAM KDM4E 4026/4885ALDH1A1 606/4885HPGD 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.